Avonex (interferon beta-1a), the new treatment for multiple sclerosis (MS)

June 1996

There's a lot of excitement about Avonex (interferon beta-1a), the new treatment for multiple sclerosis (MS).

Avonex is a beta-interferon...but it's chemically different from Betaseron (interferon beta-1b). That might explain some of the differences in their effects.

Both Avonex and Betaseron reduce the frequency of attacks in patients with the relapsing-remitting form of MS.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote